Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
152M
-
Number of holders
-
208
-
Total 13F shares, excl. options
-
123M
-
Shares change
-
+5.3M
-
Total reported value, excl. options
-
$3.46B
-
Value change
-
+$140M
-
Put/Call ratio
-
0.65
-
Number of buys
-
89
-
Number of sells
-
-94
-
Price
-
$28.06
Significant Holders of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) as of Q4 2021
245 filings reported holding ADPT - Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share as of Q4 2021.
Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) has 208 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 123M shares
of 152M outstanding shares and own 81.29% of the company stock.
Largest 10 shareholders include VIKING GLOBAL INVESTORS LP (30M shares), PRICE T ROWE ASSOCIATES INC /MD/ (13.3M shares), Matrix Capital Management Company, LP (11.6M shares), VANGUARD GROUP INC (11M shares), ARK Investment Management LLC (5.7M shares), BlackRock Inc. (5.47M shares), Sumitomo Mitsui Trust Holdings, Inc. (3.2M shares), Nikko Asset Management Americas, Inc. (3.16M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (2.43M shares), and Capital International Investors (2.09M shares).
This table shows the top 208 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.